Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 1
2008 1
2009 5
2010 5
2011 4
2012 6
2013 4
2014 3
2015 6
2016 3
2017 3
2018 7
2019 7
2020 5
2021 11
2022 9
2023 16
2024 13
2025 6

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

90 results

Results by year

Filters applied: . Clear all
Page 1
Twice-Yearly Depemokimab in Severe Asthma with an Eosinophilic Phenotype.
Jackson DJ, Wechsler ME, Jackson DJ, Bernstein D, Korn S, Pfeffer PE, Chen R, Saito J, de Luíz Martinez G, Dymek L, Jacques L, Bird N, Schalkwijk S, Smith D, Howarth P, Pavord ID; SWIFT-1 and SWIFT-2 Investigators; SWIFT-1 Investigators; SWIFT-2 Investigators. Jackson DJ, et al. N Engl J Med. 2024 Dec 19;391(24):2337-2349. doi: 10.1056/NEJMoa2406673. Epub 2024 Sep 9. N Engl J Med. 2024. PMID: 39248309 Clinical Trial.
Onset of effect and impact on health-related quality of life, exacerbation rate, lung function, and nasal polyposis symptoms for patients with severe eosinophilic asthma treated with benralizumab (ANDHI): a randomised, controlled, phase 3b trial.
Harrison TW, Chanez P, Menzella F, Canonica GW, Louis R, Cosio BG, Lugogo NL, Mohan A, Burden A, McDermott L, Garcia Gil E, Zangrilli JG; ANDHI study investigators. Harrison TW, et al. Lancet Respir Med. 2021 Mar;9(3):260-274. doi: 10.1016/S2213-2600(20)30414-8. Epub 2020 Dec 22. Lancet Respir Med. 2021. PMID: 33357499 Clinical Trial.
Expert consensus on the use of systemic glucocorticoids for managing eosinophil-related diseases.
Del Pozo V, Bobolea I, Rial MJ, Espigol-Frigolé G, Solans Laqué R, Hernández-Rivas JM, Mora E, Crespo-Lessmann A, Izquierdo Alonso JL, Domínguez Sosa MS, Maza-Solano J, Atienza-Mateo B, Bañas-Conejero D, Moure AL, Rúa-Figueroa Í. Del Pozo V, et al. Among authors: bobolea i. Front Immunol. 2024 Jan 5;14:1310211. doi: 10.3389/fimmu.2023.1310211. eCollection 2023. Front Immunol. 2024. PMID: 38250075 Free PMC article. Review.
Eicosanoid dysregulation and type 2 inflammation in AERD.
Mullol J, Boyce J, Dahlén SE, Dahlén B, Picado C, Bobolea I. Mullol J, et al. Among authors: bobolea i. J Allergy Clin Immunol. 2021 Nov;148(5):1157-1160. doi: 10.1016/j.jaci.2021.08.015. Epub 2021 Aug 28. J Allergy Clin Immunol. 2021. PMID: 34464635 No abstract available.
[Asthma: therapeutic update].
Quirce S, Bobolea I, Barranco P. Quirce S, et al. Among authors: bobolea i. Med Clin (Barc). 2014 Apr 7;142(7):317-22. doi: 10.1016/j.medcli.2013.07.012. Epub 2013 Sep 10. Med Clin (Barc). 2014. PMID: 24029450 Review. Spanish. No abstract available.
FEV1Q as a Predictive Metric for Asthma Outcomes.
Betancor D, Olaguibel JM, Del Pozo V, Alvarez Puebla MJ, Arismendi E, Barroso B, Bobolea I, Cárdaba B, Cañas JA, Domínguez-Ortega J, Cruz MJ, Curto E, Garcia de la Fuente A, González-Barcala FJ, Luna-Porta JA, Martínez-Rivera C, Mullol J, Muñoz X, Picado C, Plaza V, Quirce S, Rial MJ, Soto-Retes L, Valverde-Monge M, Mahíllo-Fernández I, Sastre J. Betancor D, et al. Among authors: bobolea i. Arch Bronconeumol. 2025 Jul;61(7):434-437. doi: 10.1016/j.arbres.2025.02.011. Epub 2025 Mar 1. Arch Bronconeumol. 2025. PMID: 40087119 English, Spanish. No abstract available.
Future biologic therapies in asthma.
Quirce S, Bobolea I, Domínguez-Ortega J, Barranco P. Quirce S, et al. Among authors: bobolea i. Arch Bronconeumol. 2014 Aug;50(8):355-61. doi: 10.1016/j.arbres.2014.02.002. Epub 2014 Mar 29. Arch Bronconeumol. 2014. PMID: 24685200 Review. English, Spanish.
90 results